Answers are grounded in this paper and cite their sources.
Background: Radiation induced fibrosis (RIF) is a chronic progressive disabling side effect of radiation therapy in cancer survivors with limited therapeutic options. Photobiomodulation therapy (PBMT) is being propagated as a non-invasive therapeutic option but has limited evidence. This scoping review aims to summarize the effects and mechanisms of PBMT in the prevention and treatment of RIF. Methods: A systematic search was conducted across five databases (PubMed, Scopus, EBSCO, ProQuest, LILACS), and three other platforms (Google Scholar, ResearchGate, Academia.edu). Retrieved studies underwent independent title, abstract, full text screening and data extraction. Quality analysis was performed for human studies to assess methodological rigor. Of these, 20 studies focused on the prevention of fibrosis, while six addressed its treatment. Preclinical studies demonstrated the beneficial effects of PBMT at different phases of fibrosis at cellular level. Clinical studies demonstrated functional improvements. Mechanisms include modulation of inflammatory pathways, fibroblast to myofibroblast conversion, collagen production, reduction of oxidative stress, and regulation of extracellular matrix remodeling. Conclusion: PBMT demonstrates potential as a non-invasive, safe therapeutic option for RIF, supported by extensive preclinical evidence. However, high-quality clinical trials are necessary to validate its clinical efficacy. Implication: PBMT offers a promising intervention for managing RIF, with potential to enhance body image, self-confidence, functional abilities, and overall quality of life for cancer survivors. This review underscores the need for further research to translate these findings into clinical practice.
No takes yet. Share an insight, caveat, or question.
Gururaj et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: